Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ex-vivo expansion of NK cells: what is the priority--high yield or high purity?

× No keyword cloud information.

14 in total

Review 1. Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Authors: Martha Luevano; Alejandro Madrigal; Aurore Saudemont
Journal: Cell Mol Immunol Date: 2012-06-18 Impact factor: 11.530

Review 2. Summit on cell therapy for cancer: The importance of the interaction of multiple disciplines to advance clinical therapy.

Authors: Cornelis J M Melief; John J O'Shea; David F Stroncek
Journal: J Transl Med Date: 2011-07-08 Impact factor: 5.531

3. Ex vivo generation of highly purified and activated natural killer cells from human peripheral blood.

Authors: Satoru Saito; Yui Harada; Yosuke Morodomi; Mitsuho Onimaru; Kumi Yoshida; Ryoichi Kyuragi; Hisahiro Matsubara; Yoshikazu Yonemitsu
Journal: Hum Gene Ther Methods Date: 2013-08 Impact factor: 2.396

Review 4. Bringing natural killer cells to the clinic: ex vivo manipulation.

Authors: Richard W Childs; Maria Berg
Journal: Hematology Am Soc Hematol Educ Program Date: 2013

5. Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens.

Authors: Laurent Boissel; Monica Betancur; Weiquan Lu; Winfried S Wels; Teresa Marino; Richard A Van Etten; Hans Klingemann
Journal: Leuk Lymphoma Date: 2011-12-06

Review 6. NK cells: immune cross-talk and therapeutic implications.

Authors: Anshu Malhotra; Anil Shanker
Journal: Immunotherapy Date: 2011-10 Impact factor: 4.196

7. Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy.

Authors: Jeffrey S Miller; Cliona M Rooney; Julie Curtsinger; Ron McElmurry; Valarie McCullar; Michael R Verneris; Natalia Lapteva; David McKenna; John E Wagner; Bruce R Blazar; Jakub Tolar
Journal: Biol Blood Marrow Transplant Date: 2014-05-09 Impact factor: 5.742

8. Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells.

Authors: Cecele J Denman; Vladimir V Senyukov; Srinivas S Somanchi; Prasad V Phatarpekar; Lisa M Kopp; Jennifer L Johnson; Harjeet Singh; Lenka Hurton; Sourindra N Maiti; M Helen Huls; Richard E Champlin; Laurence J N Cooper; Dean A Lee
Journal: PLoS One Date: 2012-01-18 Impact factor: 3.240

Review 9. Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.

Authors: Andrea Gras Navarro; Andreas T Björklund; Martha Chekenya
Journal: Front Immunol Date: 2015-04-29 Impact factor: 7.561

10. Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity.

Authors: Laurent Boissel; Monica Betancur-Boissel; Weiquan Lu; Daniela S Krause; Richard A Van Etten; Winfried S Wels; Hans Klingemann
Journal: Oncoimmunology Date: 2013-10-22 Impact factor: 8.110